Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020
08:30pm, Monday, 03'rd Aug 2020
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (Nasdaq: EGRX) today announced that the Company will release its 2020 second quarter financial results on Monday, August 10, 2020, before the mar
Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020
12:00am, Monday, 03'rd Aug 2020
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 second quarter financial
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
12:00am, Friday, 31'st Jul 2020
July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP) cellulite treatment, Osmotica Pharmaceuticals PLC's (NASDAQ: OSMT) eye...
$0.14 Earnings Per Share Expected for Eagle Pharmaceuticals Inc (NASDAQ:EGRX) This Quarter
02:46am, Wednesday, 22'nd Jul 2020
Equities research analysts forecast that Eagle Pharmaceuticals Inc (NASDAQ:EGRX) will announce $0.14 earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided e
Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
03:47pm, Friday, 17'th Jul 2020
Eagle Pharmaceuticals (NASDAQ:EGRX) has had a great run on the share market with its stock up by a significant 12...
MERIAN GLOBAL INVESTORS UK Ltd Trims Position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
06:07pm, Thursday, 16'th Jul 2020
MERIAN GLOBAL INVESTORS UK Ltd trimmed its position in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 42.1% during the second quarter, according to the company in its most recent Form 13F filing
Octapharma Reports Positive Data from octagam® Usage in Critically Ill COVID-19 Patients
12:00am, Wednesday, 15'th Jul 2020
Topline results from a retrospective study in 93 critically ill COVID-19 patients have become available. The data shows that IVIG treatment reduces in
Wells Fargo & Company MN Sells 2,611 Shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
05:44am, Tuesday, 14'th Jul 2020
Wells Fargo & Company MN decreased its holdings in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 7.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities &
Octapharma announced today that new research findings from its haematology portfolio will be presented at the upcoming International Society on Thromb
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)
04:00pm, Thursday, 09'th Jul 2020
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (NASDAQ: EGRX) today announced that the Centers for Medicare & Medicaid Services (CMS) has established a unique, product-specific billing code fo
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
08:17am, Saturday, 04'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Skandinaviska Enskilda Banken AB publ Has $1.54 Million Stock Position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
09:04am, Wednesday, 01'st Jul 2020
Skandinaviska Enskilda Banken AB publ decreased its stake in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 2.3% during the 1st quarter, according to the company in its most recent Form 13F filing with th
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
12:00am, Wednesday, 01'st Jul 2020
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular entity, or NME, approval for the month totaled...
Irish team begins clinical trial for drug therapy for severe Covid-19 infection
04:12pm, Monday, 29'th Jun 2020
Research initiated by RCSI and Beaumont Hospital to assess impact of treatment on critically ill
